Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$1.13B |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$821M |
| 3 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$770M |
| 4 |
ExxonMobil
XOM
|
+$605M |
| 5 |
Johnson & Johnson
JNJ
|
+$599M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LPT
Liberty Property Trust
LPT
|
+$139M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$75.9M |
| 3 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$48.7M |
| 4 |
Darden Restaurants
DRI
|
+$41.9M |
| 5 |
MDCO
Medicines Co
MDCO
|
+$39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.64% |
| 2 | Healthcare | 13.41% |
| 3 | Financials | 11.59% |
| 4 | Industrials | 9.19% |
| 5 | Consumer Discretionary | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPWR
2151
DELISTED
SunPower Corporation Common Stock
SPWR
| $2.67M | ﹤0.01% |
802,723
+52,734
| +7% | +$277K |
|
|
UBA
2152
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $2.65M | ﹤0.01% |
187,692
+3,598
| +2% | +$74.2K |
|
|
HSII
2153
DELISTED
Heidrick & Struggles
HSII
| $2.65M | ﹤0.01% |
117,513
+2,268
| +2% | +$60.3K |
|
2154
Ecovyst
ECVT
$1.25B
| $2.63M | ﹤0.01% |
241,181
+4,510
| +2% | +$62.6K |
|
|
AXNX
2155
DELISTED
Axonics, Inc. Common Stock
AXNX
| $2.63M | ﹤0.01% |
103,293
+8,212
| +9% | +$244K |
|
|
CNR
2156
Core Natural Resources Inc
CNR
$4.22B
| $2.62M | ﹤0.01% |
710,327
+287,508
| +68% | +$2.28M |
|
2157
Puma Biotechnology
PBYI
$407M
| $2.62M | ﹤0.01% |
309,762
-28,027
| -8% | -$272K |
|
|
DCOM
2158
DELISTED
Dime Community Bancshares
DCOM
| $2.61M | ﹤0.01% |
190,594
+1,017
| +0.5% | +$18K |
|
|
CLVS
2159
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.6M | ﹤0.01% |
408,755
+92,221
| +29% | +$740K |
|
2160
Prothena Corp
PRTA
$444M
| $2.59M | ﹤0.01% |
242,406
+3,400
| +1% | +$41.2K |
|
2161
Costamare
CMRE
$1.77B
| $2.59M | ﹤0.01% |
573,354
-78,188
| -12% | -$560K |
|
2162
Peoples Bancorp
PEBO
$1.5B
| $2.59M | ﹤0.01% |
116,752
+1,864
| +2% | +$55.5K |
|
2163
Oceaneering
OII
$4.78B
| $2.58M | ﹤0.01% |
877,917
+27,471
| +3% | +$287K |
|
2164
The RMR Group
RMR
$324M
| $2.58M | ﹤0.01% |
95,658
-2,381
| -2% | -$92.2K |
|
2165
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.7B
| $2.58M | ﹤0.01% |
+85,155
| New | +$2.6M |
|
2166
Vericel Corp
VCEL
$2.32B
| $2.57M | ﹤0.01% |
280,666
-26,341
| -9% | -$395K |
|
2167
LeMaitre Vascular
LMAT
$1.81B
| $2.57M | ﹤0.01% |
103,097
+1,382
| +1% | +$42.7K |
|
|
BDSI
2168
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $2.57M | ﹤0.01% |
677,896
+164,585
| +32% | +$809K |
|
2169
NextCure
NXTC
$21.4M
| $2.57M | ﹤0.01% |
5,774
+132
| +2% | +$70.5K |
|
2170
Vanguard High Dividend Yield ETF
VYM
$82.5B
| $2.57M | ﹤0.01% |
+36,271
| New | +$3.12M |
|
2171
Evolent Health
EVH
$346M
| $2.56M | ﹤0.01% |
472,126
+12,218
| +3% | +$109K |
|
2172
QCR Holdings
QCRH
$1.72B
| $2.56M | ﹤0.01% |
94,715
+1,485
| +2% | +$56.5K |
|
2173
Team
TISI
$78M
| $2.56M | ﹤0.01% |
39,427
+2,960
| +8% | +$367K |
|
2174
American Vanguard Corp
AVD
$73.2M
| $2.54M | ﹤0.01% |
175,791
+8,950
| +5% | +$149K |
|
2175
Magnite
MGNI
$2.96B
| $2.53M | ﹤0.01% |
456,211
+158,400
| +53% | +$1.46M |
|
Similar funds
Charles Schwab's Q1 2020 Portfolio in Review
As of Q1 2020, Charles Schwab held 3,284 positions worth $170B, down 8.5% from $186B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab deployed $31.1B of net new capital in Q1 2020, opening 103 new positions and adding to 2,418 existing holdings. Its largest new stake was iShares MBS ETF: 10,382,066 shares worth $1.15B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Darden Restaurants, an estimated $41.9M trimmed.
- Charles Schwab's largest Q1 2020 buy was iShares MBS ETF: 10,382,066 shares worth $1.15B.
- Charles Schwab added most to ExxonMobil in Q1 2020, an estimated $605M increase.
- Charles Schwab's biggest Q1 2020 reduction was Darden Restaurants, cutting an estimated $41.9M.
- Charles Schwab fully exited Liberty Property Trust in Q1 2020, selling an estimated $139M.
- Charles Schwab's ten largest holdings make up 17% of its $170B portfolio in Q1 2020.
- Charles Schwab opened 103 new positions and closed 50 in Q1 2020.
- Charles Schwab's portfolio value fell 8.5% quarter-over-quarter to $170B.
Based on Charles Schwab's 13F filing for Q1 2020, filed 15 May 2020.